Company: SMNR
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0001013762-25-003461
Chunk: 15

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 15
---
 result, a liquidator could seek to recover some, or all amounts received by our shareholders. Furthermore, our directors may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, thereby exposing themselves and our Company to claims, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons. We and our directors and officers who knowingly and willfully authorized or permitted any distribution to be paid out of our share premium account while we were unable to pay our debts as they fall due in the ordinary course of business would be guilty of an offence and may be liable to a fine and imprisonment in the Cayman Islands. The Board has fixed the close of business on March24, 2025 (the “record date”), as the date for determining the Company’s shareholders entitled to receive notice of and vote at the extraordinary general meeting and any adjournment thereof. Only holders of record of the Company’s ordinary shares on that date are entitled to have their votes counted at the extraordinary general meeting or any adjournment thereof. On the record date of the extraordinary general meeting, there were 1,261,837 Class A ordinary shares and 2,062,500 Class B ordinary shares outstanding. The Company’s warrants do not have voting rights in connection with the Extension Amendment Proposal or the Adjournment Proposal. This proxy statement contains important information about the extraordinary general meeting and the proposals. Please read it carefully and vote your shares. This proxy statement is dated March27, 2025 and is first being mailed to shareholders on or about March31, 2025.

TABLE OF CONTENTS

|                                                               |     | Page |
| QUESTIONS AND ANSWERS ABOUT THE EXTRAORDINARY GENERAL MEETING |     |    1 |
| FORWARD-LOOKING STATEMENTS                                    |     |   13 |
| RISK FACTORS                                                  |     |   14 |
| BACKGROUND                                                    |     |   18 |
| THE EXTRAORDINARY GENERAL MEETING                             |     |   21 |
| PROPOSAL 1 — THE EXTENSION AMENDMENT PROPOSAL                 |     |   22 |
| PROPOSAL 2 — THE ADJOURNMENT PROPOSAL                         |     |   28 |
| UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS               |     |   29 |
| MANAGEMENT                                                    |     |   34 |
| BEN